Removal of the paediatric posology and reminder of indication and contraindications related to serious cardiac side-effects

Systemic fluoroquinolones: risk of heart valve regurgitation

Hydrochlorothiazide - Association with non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)

Hydrochlorothiazide - Risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)

Isotretinoin - update on teratogenicity and neuropsychiatric disorders

5-Fluorouracil (i.v.) and capecitabine containing products: Pre-treatment testing to identify DPD-deficient patients at increased risk of severe toxicity.

Updated information on the reconstitution and administration of rabies vaccine, inactivated (VERORAB)

Hemlibra® (Emicizumab) and it’s known interaction with certain laboratory assays in patients who become infected with the novel corona virus that causes COVID-19

Direct Healthcare Professional Communication on the recently published epidemiological studies evaluating the risk of birth defects with Zofran® (Ondansetron)

Megamox® 625mg tablets is associated with a typographic error in the units for the weight of the product stated on the aluminum foil.